To evaluate the changes in visual impairment (VI) due to age‐related macular degeneration (AMD) during the past 40 years and the impact of novel therapies at population level. Click to show full abstract
To evaluate the changes in visual impairment (VI) due to age‐related macular degeneration (AMD) during the past 40 years and the impact of novel therapies at population level.
               
Click one of the above tabs to view related content.